A Northwestern Medicine study provides new insights into a signaling pathway in metastatic prostate cancer and suggests that a novel drug combination may improve treatment response and slow cancer growth.
Northwestern scientists have successfully transformed induced pluripotent stem cells into endometrial cells, which line the uterus and are involved in several uterine conditions such as endometrial cancer and infertility.
Northwestern Medicine scientists demonstrated how innate immune cells in inflamed tissue induce DNA damage that promotes the development of cancer.
A new full-body scan could help clinicians better assess patients during cancer treatment, according to a recent study.
Northwestern Medicine scientists have identified a gene, called isocitrate dehydrogenase 3-alpha, that promotes tumors in grade IV glioblastoma, according to a study published in Science Advances.
Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, the first step towards a pediatric leukemia “super drug.”
A drug called brentuximab vedotin combined with chemotherapy significantly improved overall survival for patients with a type of T-cell lymphoma, according to a clinical trial in The Lancet.
Northwestern Medicine scientists have discovered that an enzyme called EZH2 can activate expression of the androgen receptor gene, which drives prostate cancer growth.
Men with inflammatory bowel disease have four to five times higher risk of prostate cancer, according to a new 20-year study.
Inhibiting CHAF1B, a protein that normally helps replenish blood cells, may be a promising treatment for leukemia, according to a recent study.